857 related articles for article (PubMed ID: 11814056)
21. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
22. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
23. Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans.
Iwabuchi K; Nakayama H; Oizumi A; Suga Y; Ogawa H; Takamori K
Mediators Inflamm; 2015; 2015():120748. PubMed ID: 26609196
[TBL] [Abstract][Full Text] [Related]
24. Involvement of sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1.
Wang F; Buckley NE; Olivera A; Goodemote KA; Su Y; Spiegel S
Glycoconj J; 1996 Dec; 13(6):937-45. PubMed ID: 8981085
[TBL] [Abstract][Full Text] [Related]
25. Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells.
Törnquist K
Acta Physiol (Oxf); 2012 Feb; 204(2):151-7. PubMed ID: 21338471
[TBL] [Abstract][Full Text] [Related]
26. Lipid rafts as platforms for sphingosine 1-phosphate metabolism and signalling.
D'Aprile C; Prioni S; Mauri L; Prinetti A; Grassi S
Cell Signal; 2021 Apr; 80():109929. PubMed ID: 33493577
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.
Drexler Y; Molina J; Mitrofanova A; Fornoni A; Merscher S
J Am Soc Nephrol; 2021 Jan; 32(1):9-31. PubMed ID: 33376112
[TBL] [Abstract][Full Text] [Related]
28. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipids in liver injury, repair and regeneration.
Nojima H; Freeman CM; Gulbins E; Lentsch AB
Biol Chem; 2015 Jun; 396(6-7):633-43. PubMed ID: 25781682
[TBL] [Abstract][Full Text] [Related]
30. The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death.
Alessenko AV
Membr Cell Biol; 2000; 13(2):303-20. PubMed ID: 10779176
[TBL] [Abstract][Full Text] [Related]
31. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures.
Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A
Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280
[TBL] [Abstract][Full Text] [Related]
32. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
Nixon GF
Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
[TBL] [Abstract][Full Text] [Related]
33. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
[TBL] [Abstract][Full Text] [Related]
34. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
[TBL] [Abstract][Full Text] [Related]
35. Sphingosine 1-phosphate breakdown in platelets.
Yatomi Y; Yamamura S; Hisano N; Nakahara K; Igarashi Y; Ozaki Y
J Biochem; 2004 Oct; 136(4):495-502. PubMed ID: 15625319
[TBL] [Abstract][Full Text] [Related]
36. Partial hepatectomy activates production of the pro-mitotic intermediates of the sphingomyelin signal transduction pathway in the rat liver.
Zabielski P; Baranowski M; Zendzian-Piotrowska M; Blachnio A; Gorski J
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):277-84. PubMed ID: 17499747
[TBL] [Abstract][Full Text] [Related]
37. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipids related to apoptosis from the point of view of membrane structure and topology.
van Blitterswijk WJ; van der Luit AH; Caan W; Verheij M; Borst J
Biochem Soc Trans; 2001 Nov; 29(Pt 6):819-24. PubMed ID: 11709081
[TBL] [Abstract][Full Text] [Related]
39. The role of sphingolipids in endothelial barrier function.
Jernigan PL; Makley AT; Hoehn RS; Edwards MJ; Pritts TA
Biol Chem; 2015 Jun; 396(6-7):681-91. PubMed ID: 25867999
[TBL] [Abstract][Full Text] [Related]
40. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
